Issue of Equity

12 August 2013

Toumaz Limited

Issue of Equity in relation to Deferred Consideration

Toumaz Limited (AIM: TMZ, 'Toumaz', or 'the Company') announces that pursuant to the terms of the Acquisition Agreement (as defined in the Company's announcement of 3 July 2012), Toumaz has issued 2,677,887 new ordinary shares of 0.25p each ("Ordinary Shares") in settlement of deferred consideration due under the Acquisition Agreement.

The Company has applied for these 2,677,887 new Ordinary Shares ("New Shares") to be admitted to trading on AIM, which is expected to occur on 20th August 2013.

Following the admission to trading of the New Shares, Toumaz will have a total issued share capital of 1,198,053,901 Ordinary Shares.

There are 49,501,801 Ordinary Shares held jointly by the Employee Benefit Trust and participants for the purposes of the Company's joint share ownership plan in relation to which all voting rights have been waived.

Therefore the total number of 1,148,552,100 Ordinary Shares may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company, under the Disclosure and Transparency Rules.

For Further Enquiries: 

About Toumaz (www.toumazltd.com)

Toumaz is a pioneer in low cost, ultra-low power wireless technologies for a wide range of markets including medical monitoring and internet connected consumer devices.